摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-hydroxyazetidine salt of 1-(6-amino-3,5-difluoropyridin-2-yl)-8-chloro-6-fluoro-7-(3-hydroxyazetidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | 189279-59-2

中文名称
——
中文别名
——
英文名称
3-hydroxyazetidine salt of 1-(6-amino-3,5-difluoropyridin-2-yl)-8-chloro-6-fluoro-7-(3-hydroxyazetidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
英文别名
1-(6-Amino-3,5-difluoropyridin-2-yl)-8-chloro-6-fluoro-7-(3-hydroxyazetidin-1-yl)-4-oxoquinoline-3-carboxylic acid;azetidin-3-ol
3-hydroxyazetidine salt of 1-(6-amino-3,5-difluoropyridin-2-yl)-8-chloro-6-fluoro-7-(3-hydroxyazetidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid化学式
CAS
189279-59-2
化学式
C3H7NO*C18H12ClF3N4O4
mdl
——
分子量
513.861
InChiKey
ASRGJYFCQPKQJV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.87
  • 重原子数:
    35
  • 可旋转键数:
    3
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    152
  • 氢给体数:
    5
  • 氢受体数:
    13

反应信息

点击查看最新优质反应信息

文献信息

  • QUINOLINECARBOXYLIC ACID DERIVATIVE OR ITS SALT
    申请人:WAKUNAGA PHARMACEUTICAL CO., LTD.
    公开号:EP1219618A1
    公开(公告)日:2002-07-03
    The present invention relates to a 1-(6-amino-3,5-difluoropyridin-2-yl)-6-fluoro-7-(3-hydroxyazetidin-1-yl)-8-methyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid or salt thereof; and drugs containing the same as the active ingredient. Since this compound or salt thereof is highly stable to light while sustaining the excellent properties inherent to quinolone antibacterial agents, an antibacterial agent comprising, as an active ingredient, the invention compound or salt thereof can be stored over a long period of time without suffering from any decrease in the drug effect and can therefore be supplied as stable preparations such as injections, eye drops and surgical medicines.
    本发明涉及一种 1-(6-氨基-3,5-二氟吡啶-2-基)-6-氟-7-(3-羟基氮杂环丁烷-1-基)-8-甲基-1,4-二氢-4-氧代喹啉-3-羧酸或其盐,以及以其为活性成分的药物。由于这种化合物或其盐对光高度稳定,同时又保持了喹诺酮类抗菌剂固有的优良特性,因此含有本发明化合物或其盐作为有效成分的抗菌剂可以长期储存而不会降低药效,因此可以作为注射剂、滴眼剂和手术药物等稳定制剂供应。
  • US6586420B1
    申请人:——
    公开号:US6586420B1
    公开(公告)日:2003-07-01
  • Pyridonecarboxylic acid derivatives or their salts and antibacterial
    申请人:Wakunaga Pharmaceuticals Co., Ltd.
    公开号:US05998436A1
    公开(公告)日:1999-12-07
    A pyridonecarboxylic acid derivative represented by the following general formula (1): ##STR1## [wherein R.sup.1 represents hydrogen atom or a carboxyl protective group; R.sup.2 represents hydroxyl group, a lower alkoxy group, or a substituted or unsubstituted amino group; R.sup.3 represents hydrogen atom or a halogen atom; R.sup.4 represents hydrogen atom or a halogen atom; R.sup.5 represents a halogen atom or an optionally substituted saturated cyclic amino group; R.sup.6 represents hydrogen atom, a halogen atom, nitro group, or an optionally protected amino group; X, Y and Z may be the same or different and respectively represent nitrogen atom, --CH.dbd. or --CR.sup.7 .dbd. (wherein R.sup.7 represents a lower alkyl group, a halogen atom, or cyano group) (with the proviso that at least one of X, Y and Z represent the nitrogen atom), and W represents nitrogen atom or --CR.sup.8 .dbd. (wherein R.sup.8 represents hydrogen atom, a halogen atom, or a lower alkyl group)] or its salt, as well as an antibacterial agent containing such compound are provided.
    一种吡啶酮羧酸衍生物,由以下通式(1)表示: ##STR1## [其中R1表示氢原子或羧基保护基团;R2表示羟基、低级烷氧基或取代或未取代的氨基;R3表示氢原子或卤素原子;R4表示氢原子或卤素原子;R5表示卤素原子或可选择性取代的饱和环状氨基;R6表示氢原子、卤素原子、硝基或可选择性保护的氨基;X、Y和Z可以相同或不同,分别表示氮原子、--CH=或--CR7=(其中R7表示低级烷基、卤素原子或氰基)(条件是X、Y和Z中至少有一个表示氮原子),W表示氮原子或--CR8=(其中R8表示氢原子、卤素原子或低级烷基)]或其盐,以及含有此类化合物的抗菌剂。
查看更多